nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—glaucoma	0.675	1	CbGaD
Clodronate—Bronchoconstriction—Pilocarpine—glaucoma	0.00946	0.0443	CcSEcCtD
Clodronate—SLC25A6—eye—glaucoma	0.00728	0.173	CbGeAlD
Clodronate—SLC25A6—connective tissue—glaucoma	0.00701	0.167	CbGeAlD
Clodronate—SLC25A5—eye—glaucoma	0.00633	0.15	CbGeAlD
Clodronate—SLC25A5—connective tissue—glaucoma	0.0061	0.145	CbGeAlD
Clodronate—SLC25A4—eye—glaucoma	0.00593	0.141	CbGeAlD
Clodronate—SLC25A4—retina—glaucoma	0.00588	0.14	CbGeAlD
Clodronate—Digestion impaired—Diclofenamide—glaucoma	0.00537	0.0251	CcSEcCtD
Clodronate—Digestion impaired—Methazolamide—glaucoma	0.00495	0.0231	CcSEcCtD
Clodronate—Zoledronate—CA2—glaucoma	0.00423	1	CrCbGaD
Clodronate—SLC25A4—Hydrochlorothiazide—Diclofenamide—glaucoma	0.00418	0.473	CbGdCrCtD
Clodronate—Extravasation—Carbachol—glaucoma	0.00402	0.0188	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00386	0.0695	CbGpPWpGaD
Clodronate—Local reaction—Dorzolamide—glaucoma	0.00379	0.0177	CcSEcCtD
Clodronate—Gastrointestinal symptom NOS—Brimonidine—glaucoma	0.00374	0.0175	CcSEcCtD
Clodronate—Digestion impaired—Acetazolamide—glaucoma	0.00343	0.016	CcSEcCtD
Clodronate—Digestion impaired—Brinzolamide—glaucoma	0.00309	0.0144	CcSEcCtD
Clodronate—SLC25A4—Alprenolol—Metipranolol—glaucoma	0.00274	0.31	CbGdCrCtD
Clodronate—Hepatic function abnormal—Latanoprost—glaucoma	0.00266	0.0124	CcSEcCtD
Clodronate—PTGS2—endothelium—glaucoma	0.00243	0.0577	CbGeAlD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00232	0.0419	CbGpPWpGaD
Clodronate—Bronchospasm—Carteolol—glaucoma	0.00225	0.0105	CcSEcCtD
Clodronate—Bronchospasm—Levobunolol—glaucoma	0.00213	0.00996	CcSEcCtD
Clodronate—SLC25A4—Alprenolol—Betaxolol—glaucoma	0.00192	0.217	CbGdCrCtD
Clodronate—Hepatic function abnormal—Acetazolamide—glaucoma	0.0019	0.00889	CcSEcCtD
Clodronate—Vomiting—Physostigmine—glaucoma	0.00187	0.00876	CcSEcCtD
Clodronate—Nausea—Physostigmine—glaucoma	0.00175	0.00818	CcSEcCtD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00159	0.0286	CbGpPWpGaD
Clodronate—Connective tissue disorder—Latanoprost—glaucoma	0.00158	0.00739	CcSEcCtD
Clodronate—Proteinuria—Betaxolol—glaucoma	0.00157	0.00734	CcSEcCtD
Clodronate—Cardiac failure—Dorzolamide—glaucoma	0.00156	0.0073	CcSEcCtD
Clodronate—Protein urine present—Betaxolol—glaucoma	0.00155	0.00724	CcSEcCtD
Clodronate—Oliguria—Betaxolol—glaucoma	0.0015	0.007	CcSEcCtD
Clodronate—Mediastinal disorder—Latanoprost—glaucoma	0.00145	0.00678	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00138	0.0249	CbGpPWpGaD
Clodronate—Abdominal pain upper—Brinzolamide—glaucoma	0.00137	0.0064	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—DHPS—glaucoma	0.00135	0.0244	CbGpPWpGaD
Clodronate—Bronchospasm—Dorzolamide—glaucoma	0.0013	0.00606	CcSEcCtD
Clodronate—Pharyngitis—Apraclonidine—glaucoma	0.00128	0.00597	CcSEcCtD
Clodronate—Dyspnoea—Metipranolol—glaucoma	0.00125	0.00587	CcSEcCtD
Clodronate—Dysphagia—Pilocarpine—glaucoma	0.00124	0.00582	CcSEcCtD
Clodronate—Infection—Carbachol—glaucoma	0.00124	0.00581	CcSEcCtD
Clodronate—Pharyngitis—Bimatoprost—glaucoma	0.00124	0.00578	CcSEcCtD
Clodronate—Connective tissue disorder—Bimatoprost—glaucoma	0.00122	0.00573	CcSEcCtD
Clodronate—Bronchospasm—Pilocarpine—glaucoma	0.00122	0.00572	CcSEcCtD
Clodronate—Anorexia—Diclofenamide—glaucoma	0.00122	0.00571	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00118	0.00553	CcSEcCtD
Clodronate—Dyspnoea—Carteolol—glaucoma	0.00116	0.00544	CcSEcCtD
Clodronate—Mediastinal disorder—Apraclonidine—glaucoma	0.00116	0.00542	CcSEcCtD
Clodronate—PTGS2—connective tissue—glaucoma	0.00115	0.0273	CbGeAlD
Clodronate—Dyspepsia—Diclofenamide—glaucoma	0.00113	0.00528	CcSEcCtD
Clodronate—Anorexia—Methazolamide—glaucoma	0.00112	0.00526	CcSEcCtD
Clodronate—Mediastinal disorder—Bimatoprost—glaucoma	0.00112	0.00525	CcSEcCtD
Clodronate—Pneumonia—Pilocarpine—glaucoma	0.00112	0.00522	CcSEcCtD
Clodronate—Decreased appetite—Diclofenamide—glaucoma	0.00111	0.00521	CcSEcCtD
Clodronate—Skin disorder—Latanoprost—glaucoma	0.00111	0.00519	CcSEcCtD
Clodronate—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00111	0.00517	CcSEcCtD
Clodronate—Dyspepsia—Carbachol—glaucoma	0.0011	0.00515	CcSEcCtD
Clodronate—Dyspnoea—Levobunolol—glaucoma	0.0011	0.00514	CcSEcCtD
Clodronate—SLC25A5—Metabolism—NARFL—glaucoma	0.0011	0.0198	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CA5A—glaucoma	0.0011	0.0198	CbGpPWpGaD
Clodronate—Pharyngitis—Brimonidine—glaucoma	0.0011	0.00512	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—DHPS—glaucoma	0.00105	0.019	CbGpPWpGaD
Clodronate—Renal impairment—Betaxolol—glaucoma	0.00105	0.00492	CcSEcCtD
Clodronate—Abdominal pain upper—Clonidine—glaucoma	0.00105	0.00491	CcSEcCtD
Clodronate—Pharyngitis—Dorzolamide—glaucoma	0.00105	0.00489	CcSEcCtD
Clodronate—Pharyngitis—Travoprost—glaucoma	0.00104	0.00487	CcSEcCtD
Clodronate—Dyspepsia—Methazolamide—glaucoma	0.00104	0.00486	CcSEcCtD
Clodronate—Urinary tract disorder—Travoprost—glaucoma	0.00104	0.00485	CcSEcCtD
Clodronate—Connective tissue disorder—Travoprost—glaucoma	0.00103	0.00482	CcSEcCtD
Clodronate—Urethral disorder—Travoprost—glaucoma	0.00103	0.00481	CcSEcCtD
Clodronate—Pharyngitis—Brinzolamide—glaucoma	0.00103	0.00481	CcSEcCtD
Clodronate—Decreased appetite—Methazolamide—glaucoma	0.00103	0.0048	CcSEcCtD
Clodronate—Cardiac failure—Betaxolol—glaucoma	0.00103	0.0048	CcSEcCtD
Clodronate—Urinary tract disorder—Brinzolamide—glaucoma	0.00102	0.00479	CcSEcCtD
Clodronate—Gastrointestinal disorder—Methazolamide—glaucoma	0.00102	0.00476	CcSEcCtD
Clodronate—Dyspnoea—Latanoprost—glaucoma	0.00102	0.00476	CcSEcCtD
Clodronate—Connective tissue disorder—Brinzolamide—glaucoma	0.00102	0.00476	CcSEcCtD
Clodronate—Urethral disorder—Brinzolamide—glaucoma	0.00102	0.00475	CcSEcCtD
Clodronate—Mediastinal disorder—Brimonidine—glaucoma	0.000995	0.00465	CcSEcCtD
Clodronate—SLC25A5—Disease—LRP12—glaucoma	0.000992	0.0179	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000989	0.0178	CbGpPWpGaD
Clodronate—Abdominal pain—Carbachol—glaucoma	0.000989	0.00462	CcSEcCtD
Clodronate—Pharyngitis—Pilocarpine—glaucoma	0.000988	0.00462	CcSEcCtD
Clodronate—Urticaria—Levobunolol—glaucoma	0.000979	0.00458	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000946	0.00442	CcSEcCtD
Clodronate—Mediastinal disorder—Travoprost—glaucoma	0.000946	0.00442	CcSEcCtD
Clodronate—Urticaria—Methazolamide—glaucoma	0.000937	0.00438	CcSEcCtD
Clodronate—Mediastinal disorder—Brinzolamide—glaucoma	0.000934	0.00437	CcSEcCtD
Clodronate—SLC25A6—Metabolism—NARFL—glaucoma	0.000919	0.0166	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CA5A—glaucoma	0.000919	0.0166	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000917	0.00429	CcSEcCtD
Clodronate—Infection—Apraclonidine—glaucoma	0.000907	0.00424	CcSEcCtD
Clodronate—Pruritus—Diclofenamide—glaucoma	0.000907	0.00424	CcSEcCtD
Clodronate—Rash—Metipranolol—glaucoma	0.000887	0.00415	CcSEcCtD
Clodronate—Skin disorder—Apraclonidine—glaucoma	0.000887	0.00415	CcSEcCtD
Clodronate—Dermatitis—Metipranolol—glaucoma	0.000886	0.00415	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Betaxolol—glaucoma	0.000883	0.00413	CcSEcCtD
Clodronate—Infection—Bimatoprost—glaucoma	0.00088	0.00411	CcSEcCtD
Clodronate—Pruritus—Levobunolol—glaucoma	0.000872	0.00408	CcSEcCtD
Clodronate—Dysphagia—Betaxolol—glaucoma	0.000865	0.00405	CcSEcCtD
Clodronate—Skin disorder—Bimatoprost—glaucoma	0.00086	0.00402	CcSEcCtD
Clodronate—Diarrhoea—Carbachol—glaucoma	0.000856	0.004	CcSEcCtD
Clodronate—Bronchospasm—Betaxolol—glaucoma	0.000851	0.00398	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—CTSA—glaucoma	0.000843	0.0152	CbGpPWpGaD
Clodronate—Diarrhoea—Levobunolol—glaucoma	0.000843	0.00394	CcSEcCtD
Clodronate—Angioedema—Dorzolamide—glaucoma	0.000838	0.00392	CcSEcCtD
Clodronate—Cardiac failure—Timolol—glaucoma	0.000838	0.00392	CcSEcCtD
Clodronate—Nausea—Metipranolol—glaucoma	0.000836	0.00391	CcSEcCtD
Clodronate—SLC25A6—Disease—LRP12—glaucoma	0.000831	0.015	CbGpPWpGaD
Clodronate—Vomiting—Diclofenamide—glaucoma	0.000815	0.00381	CcSEcCtD
Clodronate—Dyspnoea—Apraclonidine—glaucoma	0.000814	0.00381	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000812	0.0038	CcSEcCtD
Clodronate—Pruritus—Latanoprost—glaucoma	0.000808	0.00378	CcSEcCtD
Clodronate—Rash—Diclofenamide—glaucoma	0.000808	0.00378	CcSEcCtD
Clodronate—Diarrhoea—Methazolamide—glaucoma	0.000807	0.00378	CcSEcCtD
Clodronate—Vomiting—Carbachol—glaucoma	0.000795	0.00372	CcSEcCtD
Clodronate—Dyspnoea—Bimatoprost—glaucoma	0.000789	0.00369	CcSEcCtD
Clodronate—Rash—Carbachol—glaucoma	0.000789	0.00369	CcSEcCtD
Clodronate—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000788	0.00369	CcSEcCtD
Clodronate—Dermatitis—Carbachol—glaucoma	0.000788	0.00369	CcSEcCtD
Clodronate—Dyspepsia—Bimatoprost—glaucoma	0.000779	0.00364	CcSEcCtD
Clodronate—Infection—Brimonidine—glaucoma	0.000779	0.00364	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—ACE2—glaucoma	0.000776	0.014	CbGpPWpGaD
Clodronate—Pneumonia—Betaxolol—glaucoma	0.000776	0.00363	CcSEcCtD
Clodronate—Nausea—Carteolol—glaucoma	0.000774	0.00362	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000772	0.00361	CcSEcCtD
Clodronate—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000764	0.00357	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000763	0.00357	CcSEcCtD
Clodronate—Skin disorder—Brimonidine—glaucoma	0.000762	0.00356	CcSEcCtD
Clodronate—Nausea—Diclofenamide—glaucoma	0.000761	0.00356	CcSEcCtD
Clodronate—Vomiting—Methazolamide—glaucoma	0.00075	0.00351	CcSEcCtD
Clodronate—Abdominal pain upper—Timolol—glaucoma	0.000747	0.00349	CcSEcCtD
Clodronate—Rash—Methazolamide—glaucoma	0.000744	0.00348	CcSEcCtD
Clodronate—Dermatitis—Methazolamide—glaucoma	0.000743	0.00348	CcSEcCtD
Clodronate—Nausea—Carbachol—glaucoma	0.000743	0.00347	CcSEcCtD
Clodronate—Infection—Travoprost—glaucoma	0.000741	0.00346	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000738	0.0133	CbGpPWpGaD
Clodronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.000732	0.0132	CbGpPWpGaD
Clodronate—Nausea—Levobunolol—glaucoma	0.000732	0.00342	CcSEcCtD
Clodronate—Infection—Brinzolamide—glaucoma	0.000731	0.00342	CcSEcCtD
Clodronate—Skin disorder—Travoprost—glaucoma	0.000724	0.00339	CcSEcCtD
Clodronate—Abdominal pain—Apraclonidine—glaucoma	0.000722	0.00338	CcSEcCtD
Clodronate—Rash—Latanoprost—glaucoma	0.00072	0.00337	CcSEcCtD
Clodronate—Dermatitis—Latanoprost—glaucoma	0.00072	0.00337	CcSEcCtD
Clodronate—Dyspepsia—Acetazolamide—glaucoma	0.000719	0.00336	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—CA1—glaucoma	0.000718	0.013	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CA5A—glaucoma	0.000717	0.0129	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NARFL—glaucoma	0.000717	0.0129	CbGpPWpGaD
Clodronate—Mediastinal disorder—Clonidine—glaucoma	0.000717	0.00335	CcSEcCtD
Clodronate—Skin disorder—Brinzolamide—glaucoma	0.000715	0.00334	CcSEcCtD
Clodronate—Anorexia—Dorzolamide—glaucoma	0.000714	0.00334	CcSEcCtD
Clodronate—Decreased appetite—Acetazolamide—glaucoma	0.00071	0.00332	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000709	0.0128	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000705	0.0033	CcSEcCtD
Clodronate—Infection—Pilocarpine—glaucoma	0.000703	0.00329	CcSEcCtD
Clodronate—Nausea—Methazolamide—glaucoma	0.000701	0.00328	CcSEcCtD
Clodronate—Dyspnoea—Brimonidine—glaucoma	0.000699	0.00327	CcSEcCtD
Clodronate—Bronchospasm—Timolol—glaucoma	0.000695	0.00325	CcSEcCtD
Clodronate—Dyspepsia—Brimonidine—glaucoma	0.00069	0.00323	CcSEcCtD
Clodronate—Pharyngitis—Betaxolol—glaucoma	0.000687	0.00321	CcSEcCtD
Clodronate—Gastrointestinal disorder—Brimonidine—glaucoma	0.000677	0.00317	CcSEcCtD
Clodronate—Anorexia—Pilocarpine—glaucoma	0.000674	0.00315	CcSEcCtD
Clodronate—Dyspnoea—Dorzolamide—glaucoma	0.000668	0.00312	CcSEcCtD
Clodronate—Dyspnoea—Travoprost—glaucoma	0.000665	0.00311	CcSEcCtD
Clodronate—Dyspepsia—Dorzolamide—glaucoma	0.000659	0.00308	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—CTSA—glaucoma	0.000658	0.0119	CbGpPWpGaD
Clodronate—Dyspnoea—Brinzolamide—glaucoma	0.000656	0.00307	CcSEcCtD
Clodronate—Dyspepsia—Travoprost—glaucoma	0.000656	0.00307	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—NGF—glaucoma	0.000655	0.0118	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000652	0.0118	CbGpPWpGaD
Clodronate—Decreased appetite—Dorzolamide—glaucoma	0.000651	0.00304	CcSEcCtD
Clodronate—SLC25A4—Disease—LRP12—glaucoma	0.000649	0.0117	CbGpPWpGaD
Clodronate—Urticaria—Acetazolamide—glaucoma	0.000649	0.00303	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000648	0.0117	CbGpPWpGaD
Clodronate—Dyspepsia—Brinzolamide—glaucoma	0.000648	0.00303	CcSEcCtD
Clodronate—Pruritus—Apraclonidine—glaucoma	0.000646	0.00302	CcSEcCtD
Clodronate—Gastrointestinal disorder—Travoprost—glaucoma	0.000644	0.00301	CcSEcCtD
Clodronate—Decreased appetite—Brinzolamide—glaucoma	0.00064	0.00299	CcSEcCtD
Clodronate—SLC25A5—Disease—FGFR1OP—glaucoma	0.000639	0.0115	CbGpPWpGaD
Clodronate—SLC25A5—Disease—HEYL—glaucoma	0.000639	0.0115	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000636	0.00297	CcSEcCtD
Clodronate—Angioedema—Clonidine—glaucoma	0.000633	0.00296	CcSEcCtD
Clodronate—Dyspnoea—Pilocarpine—glaucoma	0.000631	0.00295	CcSEcCtD
Clodronate—Pruritus—Bimatoprost—glaucoma	0.000626	0.00293	CcSEcCtD
Clodronate—Diarrhoea—Apraclonidine—glaucoma	0.000625	0.00292	CcSEcCtD
Clodronate—Mediastinal disorder—Betaxolol—glaucoma	0.000624	0.00292	CcSEcCtD
Clodronate—Dyspepsia—Pilocarpine—glaucoma	0.000623	0.00291	CcSEcCtD
Clodronate—Decreased appetite—Pilocarpine—glaucoma	0.000615	0.00288	CcSEcCtD
Clodronate—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000611	0.00286	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—ACE2—glaucoma	0.000606	0.0109	CbGpPWpGaD
Clodronate—Urticaria—Dorzolamide—glaucoma	0.000595	0.00278	CcSEcCtD
Clodronate—Abdominal pain—Dorzolamide—glaucoma	0.000592	0.00277	CcSEcCtD
Clodronate—Abdominal pain—Travoprost—glaucoma	0.000589	0.00276	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000585	0.00274	CcSEcCtD
Clodronate—Urticaria—Brinzolamide—glaucoma	0.000585	0.00273	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	0.000583	0.0105	CbGpPWpGaD
Clodronate—Vomiting—Apraclonidine—glaucoma	0.000581	0.00272	CcSEcCtD
Clodronate—Dermatitis—Apraclonidine—glaucoma	0.000575	0.00269	CcSEcCtD
Clodronate—Infection—Clonidine—glaucoma	0.000561	0.00263	CcSEcCtD
Clodronate—Abdominal pain—Pilocarpine—glaucoma	0.000559	0.00262	CcSEcCtD
Clodronate—Diarrhoea—Acetazolamide—glaucoma	0.000559	0.00261	CcSEcCtD
Clodronate—Rash—Bimatoprost—glaucoma	0.000558	0.00261	CcSEcCtD
Clodronate—Dermatitis—Bimatoprost—glaucoma	0.000558	0.00261	CcSEcCtD
Clodronate—Anaemia—Betaxolol—glaucoma	0.000557	0.00261	CcSEcCtD
Clodronate—Connective tissue disorder—Timolol—glaucoma	0.000556	0.0026	CcSEcCtD
Clodronate—Pruritus—Brimonidine—glaucoma	0.000555	0.00259	CcSEcCtD
Clodronate—Skin disorder—Clonidine—glaucoma	0.000549	0.00257	CcSEcCtD
Clodronate—Nausea—Apraclonidine—glaucoma	0.000542	0.00254	CcSEcCtD
Clodronate—Anorexia—Clonidine—glaucoma	0.000539	0.00252	CcSEcCtD
Clodronate—SLC25A6—Disease—FGFR1OP—glaucoma	0.000536	0.00966	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HEYL—glaucoma	0.000536	0.00966	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CA1—glaucoma	0.000535	0.00965	CbGpPWpGaD
Clodronate—Pruritus—Dorzolamide—glaucoma	0.00053	0.00248	CcSEcCtD
Clodronate—Pruritus—Travoprost—glaucoma	0.000527	0.00247	CcSEcCtD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000527	0.0095	CbGpPWpGaD
Clodronate—Nausea—Bimatoprost—glaucoma	0.000526	0.00246	CcSEcCtD
Clodronate—Pruritus—Brinzolamide—glaucoma	0.000521	0.00244	CcSEcCtD
Clodronate—Vomiting—Acetazolamide—glaucoma	0.000519	0.00243	CcSEcCtD
Clodronate—SLC25A5—Metabolism—CTSA—glaucoma	0.000518	0.00935	CbGpPWpGaD
Clodronate—Diarrhoea—Dorzolamide—glaucoma	0.000512	0.0024	CcSEcCtD
Clodronate—Diarrhoea—Travoprost—glaucoma	0.00051	0.00239	CcSEcCtD
Clodronate—Mediastinal disorder—Timolol—glaucoma	0.00051	0.00238	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00051	0.00238	CcSEcCtD
Clodronate—Dyspnoea—Clonidine—glaucoma	0.000504	0.00236	CcSEcCtD
Clodronate—Diarrhoea—Brinzolamide—glaucoma	0.000504	0.00236	CcSEcCtD
Clodronate—Pruritus—Pilocarpine—glaucoma	0.000501	0.00234	CcSEcCtD
Clodronate—Rash—Brimonidine—glaucoma	0.000494	0.00231	CcSEcCtD
Clodronate—Dermatitis—Brimonidine—glaucoma	0.000494	0.00231	CcSEcCtD
Clodronate—Decreased appetite—Clonidine—glaucoma	0.000491	0.0023	CcSEcCtD
Clodronate—SLC25A5—Metabolism—CA2—glaucoma	0.00049	0.00883	CbGpPWpGaD
Clodronate—Infection—Betaxolol—glaucoma	0.000489	0.00229	CcSEcCtD
Clodronate—Gastrointestinal disorder—Clonidine—glaucoma	0.000488	0.00228	CcSEcCtD
Clodronate—Nausea—Acetazolamide—glaucoma	0.000485	0.00227	CcSEcCtD
Clodronate—Diarrhoea—Pilocarpine—glaucoma	0.000484	0.00226	CcSEcCtD
Clodronate—Skin disorder—Betaxolol—glaucoma	0.000478	0.00223	CcSEcCtD
Clodronate—Vomiting—Dorzolamide—glaucoma	0.000476	0.00223	CcSEcCtD
Clodronate—Rash—Dorzolamide—glaucoma	0.000472	0.00221	CcSEcCtD
Clodronate—Dermatitis—Dorzolamide—glaucoma	0.000472	0.00221	CcSEcCtD
Clodronate—Rash—Travoprost—glaucoma	0.00047	0.0022	CcSEcCtD
Clodronate—Dermatitis—Travoprost—glaucoma	0.00047	0.0022	CcSEcCtD
Clodronate—Anorexia—Betaxolol—glaucoma	0.000469	0.00219	CcSEcCtD
Clodronate—Vomiting—Brinzolamide—glaucoma	0.000468	0.00219	CcSEcCtD
Clodronate—Nausea—Brimonidine—glaucoma	0.000466	0.00218	CcSEcCtD
Clodronate—Rash—Brinzolamide—glaucoma	0.000464	0.00217	CcSEcCtD
Clodronate—Dermatitis—Brinzolamide—glaucoma	0.000464	0.00217	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000463	0.00835	CbGpPWpGaD
Clodronate—Angioedema—Timolol—glaucoma	0.00045	0.0021	CcSEcCtD
Clodronate—Vomiting—Pilocarpine—glaucoma	0.00045	0.0021	CcSEcCtD
Clodronate—Urticaria—Clonidine—glaucoma	0.000449	0.0021	CcSEcCtD
Clodronate—SLC25A6—Metabolism—CA1—glaucoma	0.000449	0.00809	CbGpPWpGaD
Clodronate—Abdominal pain—Clonidine—glaucoma	0.000447	0.00209	CcSEcCtD
Clodronate—Rash—Pilocarpine—glaucoma	0.000446	0.00209	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000446	0.00804	CbGpPWpGaD
Clodronate—Dermatitis—Pilocarpine—glaucoma	0.000446	0.00208	CcSEcCtD
Clodronate—Nausea—Dorzolamide—glaucoma	0.000445	0.00208	CcSEcCtD
Clodronate—Nausea—Travoprost—glaucoma	0.000443	0.00207	CcSEcCtD
Clodronate—Dyspnoea—Betaxolol—glaucoma	0.000439	0.00205	CcSEcCtD
Clodronate—Nausea—Brinzolamide—glaucoma	0.000437	0.00204	CcSEcCtD
Clodronate—SLC25A6—Metabolism—CTSA—glaucoma	0.000434	0.00783	CbGpPWpGaD
Clodronate—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000433	0.00781	CbGpPWpGaD
Clodronate—Dyspepsia—Betaxolol—glaucoma	0.000433	0.00202	CcSEcCtD
Clodronate—Decreased appetite—Betaxolol—glaucoma	0.000428	0.002	CcSEcCtD
Clodronate—Gastrointestinal disorder—Betaxolol—glaucoma	0.000425	0.00199	CcSEcCtD
Clodronate—Nausea—Pilocarpine—glaucoma	0.00042	0.00197	CcSEcCtD
Clodronate—SLC25A4—Disease—FGFR1OP—glaucoma	0.000418	0.00754	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HEYL—glaucoma	0.000418	0.00754	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000416	0.00195	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—PAX6—glaucoma	0.000414	0.00746	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CA2—glaucoma	0.00041	0.0074	CbGpPWpGaD
Clodronate—Pruritus—Clonidine—glaucoma	0.0004	0.00187	CcSEcCtD
Clodronate—Infection—Timolol—glaucoma	0.000399	0.00187	CcSEcCtD
Clodronate—SLC25A5—Disease—HDAC9—glaucoma	0.000399	0.00719	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000396	0.00713	CbGpPWpGaD
Clodronate—Urticaria—Betaxolol—glaucoma	0.000391	0.00183	CcSEcCtD
Clodronate—Skin disorder—Timolol—glaucoma	0.00039	0.00183	CcSEcCtD
Clodronate—Diarrhoea—Clonidine—glaucoma	0.000387	0.00181	CcSEcCtD
Clodronate—Anorexia—Timolol—glaucoma	0.000383	0.00179	CcSEcCtD
Clodronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000383	0.0069	CbGpPWpGaD
Clodronate—Vomiting—Clonidine—glaucoma	0.000359	0.00168	CcSEcCtD
Clodronate—Dyspnoea—Timolol—glaucoma	0.000358	0.00168	CcSEcCtD
Clodronate—Rash—Clonidine—glaucoma	0.000356	0.00167	CcSEcCtD
Clodronate—Dermatitis—Clonidine—glaucoma	0.000356	0.00166	CcSEcCtD
Clodronate—Dyspepsia—Timolol—glaucoma	0.000354	0.00165	CcSEcCtD
Clodronate—SLC25A4—Metabolism—CA1—glaucoma	0.00035	0.00631	CbGpPWpGaD
Clodronate—Decreased appetite—Timolol—glaucoma	0.000349	0.00163	CcSEcCtD
Clodronate—Pruritus—Betaxolol—glaucoma	0.000348	0.00163	CcSEcCtD
Clodronate—Gastrointestinal disorder—Timolol—glaucoma	0.000347	0.00162	CcSEcCtD
Clodronate—SLC25A5—Metabolism—TXN—glaucoma	0.000345	0.00622	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CTSA—glaucoma	0.000339	0.00612	CbGpPWpGaD
Clodronate—Diarrhoea—Betaxolol—glaucoma	0.000337	0.00157	CcSEcCtD
Clodronate—Nausea—Clonidine—glaucoma	0.000336	0.00157	CcSEcCtD
Clodronate—SLC25A6—Disease—HDAC9—glaucoma	0.000334	0.00603	CbGpPWpGaD
Clodronate—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.000333	0.00601	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—PAX6—glaucoma	0.000323	0.00582	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CA2—glaucoma	0.00032	0.00577	CbGpPWpGaD
Clodronate—Urticaria—Timolol—glaucoma	0.000319	0.00149	CcSEcCtD
Clodronate—Abdominal pain—Timolol—glaucoma	0.000318	0.00149	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000313	0.00564	CbGpPWpGaD
Clodronate—Vomiting—Betaxolol—glaucoma	0.000313	0.00146	CcSEcCtD
Clodronate—Rash—Betaxolol—glaucoma	0.00031	0.00145	CcSEcCtD
Clodronate—Dermatitis—Betaxolol—glaucoma	0.00031	0.00145	CcSEcCtD
Clodronate—Nausea—Betaxolol—glaucoma	0.000292	0.00137	CcSEcCtD
Clodronate—SLC25A6—Metabolism—TXN—glaucoma	0.000289	0.00521	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000286	0.00515	CbGpPWpGaD
Clodronate—Pruritus—Timolol—glaucoma	0.000284	0.00133	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000276	0.00497	CbGpPWpGaD
Clodronate—Diarrhoea—Timolol—glaucoma	0.000275	0.00129	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TNF—glaucoma	0.000268	0.00484	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GSTT1—glaucoma	0.000267	0.00482	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HDAC9—glaucoma	0.000261	0.00471	CbGpPWpGaD
Clodronate—Vomiting—Timolol—glaucoma	0.000255	0.00119	CcSEcCtD
Clodronate—Rash—Timolol—glaucoma	0.000253	0.00118	CcSEcCtD
Clodronate—Dermatitis—Timolol—glaucoma	0.000253	0.00118	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000246	0.00443	CbGpPWpGaD
Clodronate—Nausea—Timolol—glaucoma	0.000239	0.00112	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—MMP1—glaucoma	0.000236	0.00425	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000229	0.00412	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—TXN—glaucoma	0.000226	0.00407	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GSTT1—glaucoma	0.000224	0.00404	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CDKN2B—glaucoma	0.000214	0.00387	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ABCA1—glaucoma	0.000213	0.00384	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CYP1B1—glaucoma	0.000213	0.00384	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—NGFR—glaucoma	0.00021	0.00378	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000198	0.00356	CbGpPWpGaD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000196	0.00354	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	0.000195	0.00351	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—MMP1—glaucoma	0.000184	0.00332	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—BDNF—glaucoma	0.000182	0.00329	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—MMP2—glaucoma	0.000182	0.00329	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000182	0.00328	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MTHFR—glaucoma	0.00018	0.00324	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CDKN2B—glaucoma	0.00018	0.00324	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ABCA1—glaucoma	0.000179	0.00322	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP1B1—glaucoma	0.000179	0.00322	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1A—glaucoma	0.000175	0.00316	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTT1—glaucoma	0.000175	0.00315	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GSTM1—glaucoma	0.00017	0.00307	CbGpPWpGaD
Clodronate—SLC25A5—Disease—APOE—glaucoma	0.000167	0.00302	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CAV1—glaucoma	0.000166	0.00299	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000164	0.00296	CbGpPWpGaD
Clodronate—SLC25A5—Disease—BAD—glaucoma	0.000156	0.00281	CbGpPWpGaD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000155	0.00279	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MTHFR—glaucoma	0.000151	0.00272	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—MTHFR—glaucoma	0.000151	0.00271	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000151	0.00271	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GSTM1—glaucoma	0.000143	0.00257	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—MMP2—glaucoma	0.000142	0.00257	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA5A—glaucoma	0.000142	0.00256	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NARFL—glaucoma	0.000142	0.00256	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000141	0.00254	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDKN2B—glaucoma	0.00014	0.00253	CbGpPWpGaD
Clodronate—SLC25A6—Disease—APOE—glaucoma	0.00014	0.00253	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—APOE—glaucoma	0.00014	0.00253	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ABCA1—glaucoma	0.000139	0.00251	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP1B1—glaucoma	0.000139	0.00251	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CAV1—glaucoma	0.000139	0.00251	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CAV1—glaucoma	0.000139	0.0025	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	0.000138	0.00249	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000136	0.00244	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.000132	0.00238	CbGpPWpGaD
Clodronate—SLC25A6—Disease—BAD—glaucoma	0.000131	0.00236	CbGpPWpGaD
Clodronate—PTGS2—Disease—LRP12—glaucoma	0.000128	0.00231	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—MTHFR—glaucoma	0.000126	0.00227	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS3—glaucoma	0.000125	0.00226	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000125	0.00225	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000124	0.00224	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	0.000122	0.0022	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTHFR—glaucoma	0.000118	0.00212	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—APOE—glaucoma	0.000117	0.00212	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CAV1—glaucoma	0.000116	0.0021	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—glaucoma	0.000115	0.00207	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTM1—glaucoma	0.000111	0.00201	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APOE—glaucoma	0.00011	0.00197	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CDKN1B—glaucoma	0.000109	0.00196	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CAV1—glaucoma	0.000108	0.00196	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000106	0.00192	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS3—glaucoma	0.000105	0.00189	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NOS3—glaucoma	0.000105	0.00189	CbGpPWpGaD
Clodronate—SLC25A4—Disease—BAD—glaucoma	0.000102	0.00184	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MTHFR—glaucoma	9.85e-05	0.00178	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—glaucoma	9.61e-05	0.00173	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—glaucoma	9.61e-05	0.00173	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	9.3e-05	0.00168	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOE—glaucoma	9.17e-05	0.00165	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CDKN1B—glaucoma	9.1e-05	0.00164	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CAV1—glaucoma	9.09e-05	0.00164	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	9.09e-05	0.00164	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NOS3—glaucoma	8.8e-05	0.00159	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MMP9—glaucoma	8.61e-05	0.00155	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	8.38e-05	0.00151	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGFR1OP—glaucoma	8.27e-05	0.00149	CbGpPWpGaD
Clodronate—PTGS2—Disease—HEYL—glaucoma	8.27e-05	0.00149	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS3—glaucoma	8.2e-05	0.00148	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—glaucoma	8.05e-05	0.00145	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—glaucoma	7.5e-05	0.00135	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDKN1B—glaucoma	7.11e-05	0.00128	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA1—glaucoma	6.92e-05	0.00125	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NOS3—glaucoma	6.87e-05	0.00124	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CTSA—glaucoma	6.71e-05	0.00121	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—glaucoma	6.63e-05	0.0012	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA2—glaucoma	6.33e-05	0.00114	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.33e-05	0.00114	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—glaucoma	6.28e-05	0.00113	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.19e-05	0.00112	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.19e-05	0.00112	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—glaucoma	5.84e-05	0.00105	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.26e-05	0.000949	CbGpPWpGaD
Clodronate—PTGS2—Disease—HDAC9—glaucoma	5.16e-05	0.00093	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.51e-05	0.000813	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TXN—glaucoma	4.46e-05	0.000804	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.07e-05	0.000734	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.03e-05	0.000727	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.98e-05	0.000717	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTT1—glaucoma	3.46e-05	0.000624	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN2B—glaucoma	2.77e-05	0.0005	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP1B1—glaucoma	2.76e-05	0.000497	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCA1—glaucoma	2.76e-05	0.000497	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTHFR—glaucoma	2.33e-05	0.000419	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTM1—glaucoma	2.2e-05	0.000397	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOE—glaucoma	2.16e-05	0.00039	CbGpPWpGaD
Clodronate—PTGS2—Disease—CAV1—glaucoma	2.15e-05	0.000387	CbGpPWpGaD
Clodronate—PTGS2—Disease—BAD—glaucoma	2.02e-05	0.000364	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTHFR—glaucoma	1.95e-05	0.000351	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOE—glaucoma	1.81e-05	0.000327	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CAV1—glaucoma	1.8e-05	0.000324	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS3—glaucoma	1.62e-05	0.000292	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN1B—glaucoma	1.41e-05	0.000253	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NOS3—glaucoma	1.36e-05	0.000245	CbGpPWpGaD
